Literature DB >> 30660362

Let-7a-5p inhibits BMSCs osteogenesis in postmenopausal osteoporosis mice.

Wenpu Ma1, Qingjun Dou2, Xin Ha3.   

Abstract

PURPOSE: The aim of this study was to investigate the mechanism of let-7a-5p in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in postmenopausal osteoporosis (PMOP) mice.
METHODS: A mouse model of PMOP was established and osteoporosis model was identified by micro-CT scan. BMSCs in the sham group and PMOP group were cultured and osteogenic differentiation was induced. The expression of let-7a-5p in BMSCs was detected by qRT-PCR, and BMSCs was induced by osteogenic differentiation in sham and PMOP group. The BMSCs treated by let-7a-5p mimics, let-7a-5p inhibitor and negative control were named as let-7a-5p mimics group, mimics NC group, let-7a-5p inhibitor group and inhibitor NC group, respectively. ALP staining and alizarin red staining were used to detect osteogenic differentiation ability, qRT-PCR and western blot were used to detect the expression of Runt-related transcription factor 2 (Runx2) and Osterix. The targeting relationship between let-7a-5p and TGFBR1 were verificated by target scan and luciferase reporter gene assay.
RESULTS: The PMOP mouse model was successfully established. The expression of let-7a-5p in BMSCs of PMOP group was significantly higher than that in the sham group (P < 0.05). Let-7a-5p reduced the expression of ALP and the formation of calcified nodules, while also inhibited the expression of Runx2 and Osterix. TGFBR1 is the target gene of let-7a-5p.
CONCLUSION: Let-7a-5p might inhibit the osteogenic differentiation of BMSCs in PMOP mice by regulating TGFBR1.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow mesenchymal stem cells; Let-7a-5p; Postmenopausal osteoporosis; TGFBR1

Mesh:

Substances:

Year:  2019        PMID: 30660362     DOI: 10.1016/j.bbrc.2019.01.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  [Simvastatin promotes murine osteoclasts apoptosis in vitro through NFATc1 pathway].

Authors:  Dongdong Yu; Danyang Zhao; Dongxiang Yang; Guanlin Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

2.  Differential expression of microRNAs in the hippocampi of male and female rodents after chronic alcohol administration.

Authors:  Mi Ran Choi; Jasmin Sanghyun Han; Yeung-Bae Jin; Sang-Rae Lee; In Young Choi; Heejin Lee; Hyun Cho; Dai-Jin Kim
Journal:  Biol Sex Differ       Date:  2020-11-23       Impact factor: 5.027

Review 3.  MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Maria Rosa Iaquinta; Francesca Taraballi; Elena Torreggiani; John Charles Rotondo; Lucia Otòn-Gonzalez; Elisa Mazzoni; Francesca Frontini; Ilaria Bononi; Monica De Mattei; Mauro Tognon; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 6.208

Review 4.  microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins.

Authors:  Abu Musa Md Talimur Reza; Yu-Guo Yuan
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

5.  microRNA-211-5p predicts the progression of postmenopausal osteoporosis and attenuates osteogenesis by targeting dual specific phosphatase 6.

Authors:  Huan Wang; Xiaoyan Shi; Zhenye Guo; Feng Zhao; Weifu He; Mingming Kang; Zhi Lv
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  Hsa_circ_0001485 promoted osteogenic differentiation by targeting BMPR2 to activate the TGFβ-BMP pathway.

Authors:  Shan-Chuang Chen; Tao Jiang; Qi-Yu Liu; Zi-Tao Liu; Yu-Fei Su; Hai-Tao Su
Journal:  Stem Cell Res Ther       Date:  2022-09-05       Impact factor: 8.079

Review 7.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.